This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Adaerata, Limited Partnership, Her Majesty the Queen in Right of Canada, as Represented by the Minister. Active years: 2021.
Company Filing History:
1 out of 8 
1 out of 536 Years Active: 2021
Title: Michel Chrétien: Innovator in Viral Disease Treatment
Introduction
Michel Chrétien is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of medicine, particularly in the treatment and prevention of viral diseases. His innovative approach has led to the development of a unique patent that addresses critical health challenges.
Latest Patents
Michel Chrétien holds a patent for "Methods of preventing or treating filovirus and flavivirus diseases." This patent describes a method of reducing the risk of filovirus hemorrhagic fever or its symptoms in a mammal host exposed to a filovirus, such as the Ebola or Zika virus. The method involves administering an effective amount of quercetin-3 β-O-D-glucoside (Q3G) or an analogue thereof, along with a pharmaceutically acceptable carrier, to the host prior to exposure.
Career Highlights
Throughout his career, Michel Chrétien has worked with various organizations, including Adaerata Limited Partnership and Her Majesty the Queen in Right of Canada, as represented by the Minister. His work has been instrumental in advancing medical research and developing effective treatments for viral infections.
Collaborations
Michel has collaborated with notable colleagues, including Majambu Mbikay and Xiangguo Qiu. These partnerships have contributed to the success of his research and the impact of his inventions in the medical field.
Conclusion
Michel Chrétien's innovative work in the treatment of viral diseases showcases his dedication to improving public health. His patent and collaborations highlight the importance of research and innovation in combating infectious diseases.